William D Rooney1, Yosef A Berlow2, William T Triplett2, Sean C Forbes2, Rebecca J Willcocks2, Dah-Jyuu Wang2, Ishu Arpan2, Harneet Arora2, Claudia Senesac2, Donovan J Lott2, Gihan Tennekoon2, Richard Finkel2, Barry S Russman2, Erika L Finanger2, Saptarshi Chakraborty2, Elliott O'Brien2, Brendan Moloney2, Alison Barnard2, H Lee Sweeney2, Michael J Daniels2, Glenn A Walter2, Krista Vandenborne2. 1. From the Advanced Imaging Research Center (W.D.R., Y.A.B., I.A., E.O., B.M.), Department of Neurology (W.D.R., I.A., B.S.R., E.L.F.), Department of Biomedical Engineering (W.D.R.), Department of Behavioral Neuroscience (W.D.R., Y.A.B.), and Department of Pediatrics (B.S.R., E.L.F.), Oregon Health & Science University, Portland; Departments of Physical Therapy (W.T.T., S.C.F., R.J.W., H.A., C.S., D.J.L., K.V.), Statistics (S.C., M.J.D.), Physiology and Functional Genomics (A.B., G.A.W.), and Pharmacology & Therapeutics (H.L.S.), University of Florida, Gainesville; Department of Radiology (D.-J.W.) and Division of Neurology (G.T.), Children's Hospital of Philadelphia, PA; Department of Pediatrics (R.F.), Nemours Children's Hospital, Orlando, FL; and Shriners Hospital (B.S.R., E.L.F.), Portland, OR. rooneyw@ohsu.edu. 2. From the Advanced Imaging Research Center (W.D.R., Y.A.B., I.A., E.O., B.M.), Department of Neurology (W.D.R., I.A., B.S.R., E.L.F.), Department of Biomedical Engineering (W.D.R.), Department of Behavioral Neuroscience (W.D.R., Y.A.B.), and Department of Pediatrics (B.S.R., E.L.F.), Oregon Health & Science University, Portland; Departments of Physical Therapy (W.T.T., S.C.F., R.J.W., H.A., C.S., D.J.L., K.V.), Statistics (S.C., M.J.D.), Physiology and Functional Genomics (A.B., G.A.W.), and Pharmacology & Therapeutics (H.L.S.), University of Florida, Gainesville; Department of Radiology (D.-J.W.) and Division of Neurology (G.T.), Children's Hospital of Philadelphia, PA; Department of Pediatrics (R.F.), Nemours Children's Hospital, Orlando, FL; and Shriners Hospital (B.S.R., E.L.F.), Portland, OR.
Abstract
OBJECTIVE: To quantify disease progression in individuals with Duchenne muscular dystrophy (DMD) using magnetic resonance biomarkers of leg muscles. METHODS: MRI and magnetic resonance spectroscopy (MRS) biomarkers were acquired from 104 participants with DMD and 51 healthy controls using a prospective observational study design with patients with DMD followed up yearly for up to 6 years. Fat fractions (FFs) in vastus lateralis and soleus muscles were determined with 1H MRS. MRI quantitative T2 (qT2) values were measured for 3 muscles of the upper leg and 5 muscles of the lower leg. Longitudinal changes in biomarkers were modeled with a cumulative distribution function using a nonlinear mixed-effects approach. RESULTS: MRS FF and MRI qT2 increased with DMD disease duration, with the progression time constants differing markedly between individuals and across muscles. The average age at half-maximal muscle involvement (μ) occurred 4.8 years earlier in vastus lateralis than soleus, and these measures were strongly associated with loss-of-ambulation age. Corticosteroid treatment was found to delay μ by 2.5 years on average across muscles, although there were marked differences between muscles with more slowly progressing muscles showing larger delay. CONCLUSIONS: MRS FF and MRI qT2 provide sensitive noninvasive measures of DMD progression. Modeling changes in these biomarkers across multiple muscles can be used to detect and monitor the therapeutic effects of corticosteroids on disease progression and to provide prognostic information on functional outcomes. This modeling approach provides a method to transform these MRI biomarkers into well-understood metrics, allowing concise summaries of DMD disease progression at individual and population levels. CLINICALTRIALSGOV IDENTIFIER: NCT01484678.
OBJECTIVE: To quantify disease progression in individuals with Duchenne muscular dystrophy (DMD) using magnetic resonance biomarkers of leg muscles. METHODS: MRI and magnetic resonance spectroscopy (MRS) biomarkers were acquired from 104 participants with DMD and 51 healthy controls using a prospective observational study design with patients with DMD followed up yearly for up to 6 years. Fat fractions (FFs) in vastus lateralis and soleus muscles were determined with 1H MRS. MRI quantitative T2 (qT2) values were measured for 3 muscles of the upper leg and 5 muscles of the lower leg. Longitudinal changes in biomarkers were modeled with a cumulative distribution function using a nonlinear mixed-effects approach. RESULTS: MRS FF and MRI qT2 increased with DMD disease duration, with the progression time constants differing markedly between individuals and across muscles. The average age at half-maximal muscle involvement (μ) occurred 4.8 years earlier in vastus lateralis than soleus, and these measures were strongly associated with loss-of-ambulation age. Corticosteroid treatment was found to delay μ by 2.5 years on average across muscles, although there were marked differences between muscles with more slowly progressing muscles showing larger delay. CONCLUSIONS: MRS FF and MRI qT2 provide sensitive noninvasive measures of DMD progression. Modeling changes in these biomarkers across multiple muscles can be used to detect and monitor the therapeutic effects of corticosteroids on disease progression and to provide prognostic information on functional outcomes. This modeling approach provides a method to transform these MRI biomarkers into well-understood metrics, allowing concise summaries of DMD disease progression at individual and population levels. CLINICALTRIALSGOV IDENTIFIER: NCT01484678.
Authors: Craig M McDonald; Erik K Henricson; Richard T Abresch; Tina Duong; Nanette C Joyce; Fengming Hu; Paula R Clemens; Eric P Hoffman; Avital Cnaan; Heather Gordish-Dressman Journal: Lancet Date: 2017-11-22 Impact factor: 79.321
Authors: Sean C Forbes; Rebecca J Willcocks; William D Rooney; Glenn A Walter; Krista Vandenborne Journal: Lancet Neurol Date: 2015-11-06 Impact factor: 44.182
Authors: Robert C Griggs; J Phillip Miller; Cheryl R Greenberg; Darcy L Fehlings; Alan Pestronk; Jerry R Mendell; Richard T Moxley; Wendy King; John T Kissel; Valerie Cwik; Michel Vanasse; Julaine M Florence; Shree Pandya; Jordan S Dubow; James M Meyer Journal: Neurology Date: 2016-08-26 Impact factor: 9.910
Authors: Alison M Barnard; Rebecca J Willcocks; Erika L Finanger; Michael J Daniels; William T Triplett; William D Rooney; Donovan J Lott; Sean C Forbes; Dah-Jyuu Wang; Claudia R Senesac; Ann T Harrington; Richard S Finkel; Barry S Russman; Barry J Byrne; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne Journal: PLoS One Date: 2018-03-19 Impact factor: 3.240
Authors: Alison M Barnard; Donovan J Lott; Abhinandan Batra; William T Triplett; Rebecca J Willcocks; Sean C Forbes; William D Rooney; Michael J Daniels; Barbara K Smith; Krista Vandenborne; Glenn A Walter Journal: Chest Date: 2021-09-15 Impact factor: 10.262
Authors: Rebecca J Willcocks; Alison M Barnard; Ryan J Wortman; Claudia R Senesac; Donovan J Lott; Ann T Harrington; Kirsten L Zilke; Sean C Forbes; William D Rooney; Dah-Jyuu Wang; Erika L Finanger; Gihan I Tennekoon; Michael J Daniels; William T Triplett; Glenn A Walter; Krista Vandenborne Journal: J Neuromuscul Dis Date: 2022
Authors: Kavya S Nair; Donovan J Lott; Sean C Forbes; Alison M Barnard; Rebecca J Willcocks; Claudia R Senesac; Michael J Daniels; Ann T Harrington; Gihan I Tennekoon; Kirsten Zilke; Erika L Finanger; Richard S Finkel; William D Rooney; Glenn A Walter; Krista Vandenborne Journal: J Neuromuscul Dis Date: 2022
Authors: Christopher Lopez; Tanja Taivassalo; Maria G Berru; Andres Saavedra; Hannah C Rasmussen; Abhinandan Batra; Harneet Arora; Alex M Roetzheim; Glenn A Walter; Krista Vandenborne; Sean C Forbes Journal: J Appl Physiol (1985) Date: 2021-05-20
Authors: Thom T J Veeger; Nienke M van de Velde; Kevin R Keene; Erik H Niks; Melissa T Hooijmans; Andrew G Webb; Jurriaan H de Groot; Hermien E Kan Journal: NMR Biomed Date: 2022-02-05 Impact factor: 4.478
Authors: Thom T J Veeger; Erik W van Zwet; Diaa Al Mohamad; Karin J Naarding; Nienke M van de Velde; Melissa T Hooijmans; Andrew G Webb; Erik H Niks; Jurriaan H de Groot; Hermien E Kan Journal: Muscle Nerve Date: 2021-08-25 Impact factor: 3.852
Authors: Adrienne Samani; Rylie M Hightower; Andrea L Reid; Katherine G English; Michael A Lopez; J Scott Doyle; Michael J Conklin; David A Schneider; Marcas M Bamman; Jeffrey J Widrick; David K Crossman; Min Xie; David Jee; Eric C Lai; Matthew S Alexander Journal: Life Sci Alliance Date: 2022-05-05